Combinations of proteasome inhibitors with obatoclax are effective for small cell lung cancer
Yanping Yin(University of Science and Technology of China), Wenchu Lin(Chinese University of Hong Kong, Shenzhen)
Cited by 12
Related Papers
Exosomal miR-92b-3p Promotes Chemoresistance of Small Cell Lung Cancer Through the PTEN/AKT Pathway
|Frontiers in Cell and Developmental Biology|2021|46
The dual HDAC-PI3K inhibitor CUDC-907 displays single-agent activity and synergizes with PARP inhibitor olaparib in small cell lung cancer
|Journal of Experimental & Clinical Cancer Research|2020|46
FK228 potentiates topotecan activity against small cell lung cancer cells via induction of SLFN11
|Acta Pharmacologica Sinica|2021|25
FK228 sensitizes radioresistant small cell lung cancer cells to radiation
|Clinical Epigenetics|2021|17
BRCA1 orchestrates the response to BI-2536 and its combination with alisertib in MYC-driven small cell lung cancer
|Cell Death and Disease|2024|10